Jeremy J. Johnson
Professor, Pharmacy Practice
Assistant Head, Research, Pharmacy Practice
Member, Cancer Center – Translational Oncology Program
Clinical Pharmacist, College of Pharmacy
About Heading link
Teaching and Supervision Heading link
PSCI Ph.D. Thesis Research (PSCI 599), 1/9/2023 – 4/28/2023
Special Proj Pharm Sci (PSCI 390), 1/9/2023 – 4/28/2023
Undergrad Res Pharm Sci (PSCI 380), 1/9/2023 – 4/28/2023
PDAT 8: Special Topics (PHAR 508), 8/22/2022 – 12/2/2022
Doctoral Research in Pharmacog (PMPG 599), 8/22/2022 – 12/2/2022
Undergrad Resrch Pharm Pract (PMPR 380), 8/22/2022 – 12/2/2022
PDAT 8: Special Topics (PHAR 508), 8/22/2022 – 12/2/2022
PSCI Ph.D. Thesis Research (PSCI 599), 8/22/2022 – 12/2/2022
PSCI Ph.D. Thesis Research (PSCI 599), 1/10/2022 – 4/29/2022
B3166 : VIDAS� NEPHROCLEARTM CCL14 : Sample Stability Study, Reference number 423961, bioMerieux., 12/9/2021 - 8/31/2023, Obligated Amount: $76998; Anticipated Amount: $76998
Implications of MTHFR Polymorphisms in Women receiving a Combination of Green Tea Extract and Fertility Promoting Drugs on Serum Folate Levels, NIH - NICHD - National Institute of Child Health & Human Development., 9/1/2020 - 8/31/2021, Obligated Amount: $159900; Anticipated Amount: $159900
Use of Carnosic Acid and VivOX4 0 for Breast Cancer Prevention, National Institutes of Health (National Cancer Institute)., 7/1/2020 - 12/30/2024, Obligated Amount: $1683454; Anticipated Amount: $1683454
, 7/1/2020 - 6/30/2025, No Obligated Amount Set; No Anticipated Amount Set
Pilot Study to Develop and Test a Multiplex Assay for CYP450 Phenotyping in Multiple Myeloma Patients Receiving Bortezomib, Hematology Oncology Pharmacy Association (HOPA)., 3/1/2020 - 7/28/2023, Obligated Amount: $85283; Anticipated Amount: $85283
3/4, University of Illinois at Chicago Clinical Site- Reproductive Medicine Collaborative Consortium: A randomized placebo-controlled trial of EGCG to improve fertility in women with uterine fibroids, National Institutes of Health (Eunice Kennedy Shriver National Institute of Child Health and Human Development)., 9/26/2019 - 8/31/2024, Obligated Amount: $1635892; Anticipated Amount: $1749905
Determinants of transdermal drug delivery to the normal and the radiated breast, Northwestern University., 2/5/2019 - 1/31/2024, Obligated Amount: $127789; Anticipated Amount: $127789
Defining the role of isoprenylated xanthones from the mangosteen for enhancing degradation of full length and variant forms of androgen receptor in prostate cancer, National Institutes of Health (National Cancer Institute)., 1/1/2019 - 12/31/2023, Obligated Amount: $1758062; Anticipated Amount: $1765131
Identification of Preclinical Drug Candidates for the Treatment of Schistosomiasis, Rush University Medical Center., 12/1/2018 - 11/30/2022, Obligated Amount: $578006; Anticipated Amount: $578006
Rodríguez, Rocío Rivera, Johnson, Jeremy James. (2023). Terpenes: Modulating anti-inflammatory signaling in inflammatory bowel disease.. Pharmacol Ther, 108456. doi:10.1016/j.pharmthera.2023.108456.
Sweiss, Karen, Patel, Pritesh, Guo, Janet, Kim, Kyeongmin, Hill, Kasey, Abbott, Nicole, Johnson, Jeremy, Irby, Donald, Quigley, John G, Rondelli, Damiano, Harvey, R Donald, Nooka, Ajay K, Dhodapkar, Madhav, Kaufman, Jonathan L, Joseph, Nisha S, Lonial, Sagar, Sborov, Douglas W, Phelps, Mitch A, Hofmeister, Craig C. (2022). Phase 1 Trial of AUC-Targeted Melphalan in Myeloma Patients Undergoing Autologous Transplant (The MyMel Study). Blood, 140, (Supplement 1), 5988-5990. doi:10.1182/blood-2022-170778.
Gurgul, Aleksandra, Nauman, Mirielle C, Wu, Zhenlong, Shetye, Gauri, Ma, Rui, Youn, Isoo, Souliya, Onevilay, Bisson, Jonathan, Johnson, Jeremy J, Che, Chun-Tao. (2022). Chemical constituents of the stem of Marsypopetalum modestum and their bioactivities.. Natural Product Research, 1-8. doi:10.1080/14786419.2022.2097229.
Nauman, Mirielle C, Johnson, Jeremy J. (2022). The purple mangosteen (Garcinia mangostana): Defining the anticancer potential of selected xanthones. Pharmacological Research, 175, 106032. doi:10.1016/j.phrs.2021.106032.
Nauman, Mirielle C, Tocmo, Restituto, Vemu, Bhaskar, Veenstra, Jacob P, Johnson, Jeremy J. (2021). Inhibition of CDK2/CyclinE1 by xanthones from the mangosteen (Garcinia mangostana): a structure-activity relationship study. Natural Product Research, 35, (23), 5429-5433. doi:10.1080/14786419.2020.1777413.
Vemu, Bhaskar, Tocmo, Restituo, Nauman, Mirielle C, Flowers, Stephanie A, Veenstra, Jacob P, Johnson, Jeremy J. (2021). Pharmacokinetic characterization of carnosol from rosemary (Salvia Rosmarinus) in male C57BL/6 mice and inhibition profile in human cytochrome P450 enzymes. Toxicology and Applied Pharmacology, 431, 115729. doi:10.1016/j.taap.2021.115729.
Siblini, Hiba, Al-Hendy, Ayman, Segars, James H, Singh, Bhuchitra, Taylor, Hugh S, Flores, Valerie A, González, Frank, Christman, Gregory M, Johnson, Jeremy J, Huang, Hao, Zhang, Heping. (2021). EPIGALLOCATECHIN GALLATE (EGCG) FOR TREATMENT OF UNEXPLAINED INFERTILITY ASSOCIATED WITH UTERINE FIBROIDS (PRE-FRIEND TRIAL): EARLY SAFETY ASSESSMENT. Fertility and Sterility, 116, (3), e318-e319. doi:10.1016/j.fertnstert.2021.07.857.
Bailey, Howard H, Johnson, Jeremy J, Lozar, Taja, Scarlett, Cameron O, Wollmer, Barbara W, Kim, KyungMann, Havinghurst, Thomas, Ahmad, Nihal. (2021). A randomized, double-blind, dose-ranging, pilot trial of piperine with resveratrol on the effects on serum levels of resveratrol.. European Journal of Cancer Prevention, 30, (3), 285-290. doi:10.1097/cej.0000000000000621.
Sweiss, Karen, Calip, Gregory Sampang, Holden, Jaime, Lewkowski, Paulina, Mialik, Iryna, Johnson, Jeremy, Galvin, John P, Rondelli, Damiano, Patel, Pritesh. (2021). Predictors of increased melphalan exposure correlate with overall survival, nonrelapse mortality, and toxicities in patients undergoing reduced-intensity allogeneic stem cell transplantation with fludarabine and melphalan. Journal of Oncology Pharmacy Practice, 27, (3), 579-587. doi:10.1177/1078155220927436.
Board Member, 7/1/2022 - Present
2015, Hans W. Vahlteich UIC Research Scholar, University of Illinois at Chicago
B.S., University of Wisconsin–Stevens Point, United States, 2001
Pharm.D., University of Wisconsin Hospital and Clinics, United States, 2007
Ph.D., University of Wisconsin School of Medicine and Public Health, United States, 2010
Licensures and Certifications
Registered Pharmacist, Wisconsin Department of Safety and Professional Services, 10/2007 - Present
Registered Pharmacist, Illinois Department of Financial and Professional Regulation, 3/2011 - Present
Johnson, Jeremy. (2022 June 22). Pharmacological and Pharmacokinetic properties of rosemary for prostate cancer.. 26th Biannual Pharmacognosy Conference. Ankara Turkey.